Filing Details
- Accession Number:
- 0001209191-19-048892
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-09-09 16:20:01
- Reporting Period:
- 2019-09-06
- Accepted Time:
- 2019-09-09 16:20:01
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1438133 | Tandem Diabetes Care Inc | TNDM | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1365369 | F John Sheridan | C/O Tandem Diabetes Care, Inc., 11075 Roselle Street San Diego CA 92121 | President & Ceo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-09-06 | 9,538 | $2.59 | 12,039 | No | 4 | M | Direct | |
Common Stock | Disposition | 2019-09-06 | 9,538 | $70.03 | 2,501 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option | Disposition | 2019-09-06 | 9,538 | $0.00 | 9,538 | $2.59 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
32,129 | No | 4 | M | Direct |
Footnotes
- Represents shares of common stock received upon exercise of a stock option award.
- The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 6, 2019.
- The price reported is the weighted average price. The shares were sold in multiple transactions at prices ranging from $70.00 to $70.05. The reporting person undertakes to provide the SEC, the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
- Fifty percent (50%) of the underlying shares subject to the option vested on 12/1/2018, and the remaining shares shall vest in twelve (12) equal monthly installments thereafter
- The expiration date for these options is ten (10) years from the date of grant.